GE HealthCare unveils innovative AI-enabled imaging and digital health solutions at 50th edition of Arab Health
From AI-enabled imaging to streamlined workflows, GE HealthCare's latest innovations empower healthcare providers to deliver more precise, personalized care
Dubai, UAE: GE HealthCare, a leading global medical technology and digital solutions innovator, will announce key collaboration agreements and unveil groundbreaking AI-enabled imaging, ultrasound, and digital innovations in precision care at the 50th anniversary of Arab Health, held from January 27 – 30 at the Dubai World Trade Centre. These advancements in imaging, ultrasound, patient care, and pharmaceutical diagnostics are designed to shape the future of healthcare and address critical healthcare needs across the Eurasian and African Growth Markets (EAGM).
In the presence of more than 3,800 exhibitors from 180+ countries and a host of healthcare professionals and delegates at Arab Health 2025, GE HealthCare will demonstrate its commitment to transforming healthcare delivery in the region and beyond by showcasing its wide range of intelligent technologies and solutions that integrate seamlessly along clinical care pathways, including oncology, cardiology, and neurology. In key markets like the UAE, Saudi Arabia, Turkey, and Egypt, GE HealthCare has been expanding its broad range of artificial intelligence (AI) enabled devices to revamp existing hospital practices, better inform clinical decision-making, and improve patient outcomes.
Kostas Deligiannis, Zone President, Eurasian & African Growth Markets (EAGM), GE HealthCare, said: "Building on a 50-year legacy in the EAGM region, GE HealthCare is driving the next wave of transformation in healthcare. We continue to invest in innovative AI and digital solutions to address the region's unique challenges and evolving needs, partnering with local providers to deliver impactful solutions that offer a more personal, precise, and human-focused approach across the care continuum. At Arab Health's 50th anniversary, we are proud to showcase solutions that can help transform hospital practices and pave the way for a future-ready healthcare ecosystem."
GE HealthCare will present a wide range of leading next-generation solutions and AI-enabled devices at Arab Health 2025 to help streamline workflows, increase efficiency, and drive better patient care, clinical decisions, or outcomes. A mockup of the SIGNA™ Champion MR machine, which provides natural patient positioning for even the most challenging cases, will be on show at the GE HealthCare booth. Powered by advanced technologies like AIR™ Recon DL and AIR™ Coils, it is equipped with a 'green' intelligent magnet technology that optimizes low helium operations, enhancing cost-effectiveness without compromising system performance.
GE HealthCare will also display the new Revolution™ Advance CT at Arab Health. Ideal for routine clinical capabilities, this CT scanner is easy to use and operate, while also delivering outstanding image quality and keeping patients comfortable.
The highlight in mammography systems is the all-new Pristina Via which makes acquisition effortless, including with zero-click acquisition. It provides superior diagnostic accuracy compared with 2D alone, for all breast densities. Despite its advances and future focus, it has full backward compatibility and the system's advanced features automate processes, allowing users to give patients the attentive, quality care they deserve.
At Arab Health 2025, GE HealthCare will also feature three ultrasound systems, including two with AI functionality. The ultra-portable Vscan Air™ SL with Caption AI supports rapid and confident assessments at the point of care. It provides real-time, step-by-step guidance on maneuvering the probe to capture diagnostic-quality standard echocardiographic views. The comprehensive Discover LOGIQ Totus™ ultrasound solution features AI-powered decision support and workflow technology, high-quality imaging, specialty tools, and a sleek design while the all-in-one, entry-level Venue Sprint™ delivers uncompromised image quality and smart workflows, combined with the freedom and maximum portability of wireless probes.
GE HealthCare will also join forces with key industry stakeholders, forging collaborations that build a healthier, more sustainable future. GE HealthCare is located at stand S3.B10 at the Dubai World Trade Centre.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
6 days ago
- Al Etihad
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
3 June 2025 14:30 ABU DHABI (ALETIHAD)M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood approach does not replace but rather complements routine cancer screenings, and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said, 'This collaboration reflects our vision of democratising health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalised care.'Sameh El Fangary, Cluster President GCC of AstraZeneca, stated, "Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimising patient pathways from detection to therapy.' Ross Muken, President of SOPHiA GENETICS, said, "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalise care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." Source: Aletihad - Abu Dhabi
TECHx
31-05-2025
- TECHx
Starkey MEA Unveils Edge AI for Better Hearing Month
Home » Smart Sectors » Healthcare » Starkey MEA Unveils Edge AI for Better Hearing Month Starkey MEA has announced its most advanced hearing solution to date is Edge AI. The launch is part of its ongoing campaign to promote hearing health awareness across the Middle East during Better Hearing Month. Edge AI is designed to replicate how the human brain processes sound. It performs up to 80 million personalized hearing adjustments per hour. This helps users stay connected, confident, and comfortable in any setting. At the core of the device is Starkey's G2 Neuro Processor. It features six times more transistors, ten times more memory, and four times faster processing than its predecessor. As a result, Edge AI can automatically adapt to complex sound environments. Whether it's a majlis in the UAE, a busy street in Jeddah, or a mall in Kuwait City, the device ensures real-time auditory clarity. Giscard Bechara, Regional Director, MEA, Starkey Laboratories Inc., stated that Edge AI is more than a hearing aid. He called it 'a technological breakthrough designed for real life.' He also emphasized the importance of early diagnosis and preventive check-ups for better hearing. Edge AI includes features that enhance connectivity, wellness, and convenience: Bluetooth LE Audio and Auracast™ broadcast for efficient streaming StarLink Edge TV Streamer, 60% smaller than before Select waterproof models offering up to 51 hours of battery life The device also integrates Neuro Sound Technology 2.0. This provides 30% more accurate speech detection in noisy environments. Dr. Mohamed Ali Eltom, Chairman of the International Diabetes Federation (MENA region), shared his experience. He reported that Edge AI restored his ability to engage in both professional and social settings. He described the device as a 'lifeline' for people who rely on communication. Additionally, Edge AI supports a holistic approach to hearing care. It includes sensor-driven balance assessments, fall detection alerts, and smartwatch integration via the My Starkey app. Users can manage hearing settings and track wellness on the go. Starkey MEA revealed that hearing loss is increasing across the region. Factors include exposure to prolonged noise and an ageing population. The company is working with audiologists and clinics to raise awareness, encourage early screening, and offer access to its latest technology during Better Hearing Month. Bechara added that better hearing leads to better living. He called Edge AI the company's most powerful solution and urged the public to take the first step toward hearing health.
Arabian Business
08-05-2025
- Arabian Business
cost of GCC healthcare
GCC healthcare sector urged to unlock $2.5bn by investing in staff wellbeing by GCC healthcare professionals face burnout worries unless industry heads invest in staff wellbeing Latest in cost of GCC healthcare In pictures: WHO logistics hub in Dubai carried 7.5 tonnes of medical supplies to Iran by ITP Tue 3 Mar 2020 Dubai's International Humanitarian City facilitated the shipment containing medical supplies that could assist some 15,000 healthcare workers taking care of coronavirus patients in Iran In pictures: Sheikh Mohammed visits Arab Health Exhibition 2020 by ITP Tue 28 Jan 2020 Arab Health 2020 is taking place at the Dubai World Trade Centre and Conrad Dubai Hotel from 27 – 30 January 2020
